Zolpidem Tartrate
Product Images NDC 50090-3994

3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 50090-3994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903994)

Label Image (Lbl500903994)
Label for Zolpidem Tartrate Extended-Release 6.25 mg tablets by A-S Medication Solutions. Shows NDC 50090-3994-0, product number 6378-0, storage instructions, and packaging details for a 20-count bottle of extended-release tablets.*
FDA Label Image

Molecular-structure.jpg (Zolpidem Tartrate Extended Release Tablets 1)

Molecular-structure.jpg (Zolpidem Tartrate Extended Release Tablets 1)
Chemical structure diagram showing the molecular formula of zolpidem tartrate, the active ingredient of Zolpidem Tartrate Extended-Release by A-S Medication Solutions. The image illustrates two molecular configurations including the zolpidem moiety and tartaric acid components.*
FDA Label Image

Figure-1.jpg (Zolpidem Tartrate Extended Release Tablets 2)

Figure-1.jpg (Zolpidem Tartrate Extended Release Tablets 2)
Line graph comparing zolpidem plasma concentrations (ng/mL) over time (hours) between 12.5 mg zolpidem tartrate extended-release and 10 mg zolpidem tartrate immediate-release formulations. The graph shows plasma concentration rising quickly for immediate release then declining, while extended release sustains higher concentrations over a longer duration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.